Component of Parent Org(s):
Effective Date and Time of Initial Listing: February 25, 2009 12:01 AM ET
PSO Mailing Address: 10809 Executive Center Drive, Searcy Building, Suite 300, Little Rock, AR 72211
PSO Phone Number: (501) 225-5533, ext. 103
Two Bona Fide Contract Requirement: Next attestation period is 02/25/2019 through 02/24/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Component of Parent Org(s):
Effective Date and Time of Initial Listing: May 11, 2011 12:01 AM ET
PSO Mailing Address: 4600 Edmundson Road, St. Louis, MO 63134
PSO Phone Number: 314-733-8164
Two Bona Fide Contract Requirement: Next attestation period is 05/11/2021 through 05/10/2023
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: Yes
Effective Date and Time of Initial Listing: October 19, 2017 12:01 AM ET
PSO Mailing Address: 16011 S. 108th Ave., Orland Park, IL 60467
PSO Phone Number: (833) 216-7931
Two Bona Fide Contract Requirement: Next attestation period is 10/19/2019 through 10/18/2021
Disclosures & Finding: None
Component of Parent Org(s): - Center for Leadership, Innovation and Research in EMS
Effective Date and Time of Initial Listing: November 28, 2012 12:01 AM ET
PSO Mailing Address: PO Box 2286, St. Cloud, MN 56302
PSO Phone Number: 919-448-8618
Two Bona Fide Contract Requirement: Next attestation period is 11/28/2018 through 11/27/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Component of Parent Org(s):
Effective Date and Time of Initial Listing: July 24, 2018 12:01 AM ET
PSO Mailing Address: 3165 E Millrock Dr. Suite 400, Salt Lake City, UT 84121
PSO Phone Number: (801) 708-6800
Two Bona Fide Contract Requirement: Next attestation period is 07/24/2020 through 07/23/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Component of Parent Org(s): - Louisiana Hospital Association
Effective Date and Time of Initial Listing: November 8, 2016 12:01 AM ET
PSO Mailing Address: 9521 Brookline Ave, Baton Rouge, LA 70809
PSO Phone Number: 225-928-0026
Two Bona Fide Contract Requirement: Next attestation period is 11/08/2020 through 11/07/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Component of Parent Org(s):
Effective Date and Time of Initial Listing: December 14, 2015 12:01 AM ET
PSO Mailing Address: 702 SW 8th Street Mailstop 430, Bentonville, AR 72716
PSO Phone Number: 479-204-9188
Two Bona Fide Contract Requirement: Next attestation period is 12/14/2019 through 12/13/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Component of Parent Org(s):
Effective Date and Time of Initial Listing: June 19, 2013 12:01 AM ET
PSO Mailing Address: PO Box 1418, Palmetto, FL 34221
PSO Phone Number: (810) 210-9885
Two Bona Fide Contract Requirement: Next attestation period is 06/19/2019 through 06/18/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Component of Parent Org(s): - Texas Hospital Association Foundation
Effective Date and Time of Initial Listing: November 14, 2012 12:01 AM ET
PSO Mailing Address: 1108 Lavaca Street, Suite 700, Austin, TX 78701
PSO Phone Number: 512-465-1000
Two Bona Fide Contract Requirement: Next attestation period is 11/14/2018 through 11/13/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Component of Parent Org(s):
Effective Date and Time of Initial Listing: September 14, 2018 12:01 AM ET
PSO Mailing Address: 1985 Marcus Avenue Suite LL 106, Lake Success, NY 11042
PSO Phone Number: (516) 321-6363
Two Bona Fide Contract Requirement: Next attestation period is 09/14/2018 through 09/13/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Component of Parent Org(s):
Effective Date and Time of Initial Listing: April 22, 2014 12:01 AM ET
PSO Mailing Address: 367 South Gulph Road, King of Prussia, PA 19406
PSO Phone Number: (610) 382-3385
Two Bona Fide Contract Requirement: Next attestation period is 04/22/2018 through 04/21/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: Yes